pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·13h ago·1 min read
save

STAT+: A scientist-turned-biotech executive is notching some wins, and enjoying it

Aug 6, 2026·read at STAT ↗

Scientist-turned-biotech executive Greg Verdine is having a very good year.

source

Reporting by STAT. The original article may no longer be reachable at its published URL.

read at STAT ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoSTAT+: FDA approves Replimune melanoma drug previously rejected twiceSTAT
  • 4h agoSTAT+: Medicare quietly gave blockbuster AbbVie drug seven extra years before price negotiations, advocacy group assertsSTAT
  • 8h agoSTAT+: Study reveals new role for tau, a top target for Alzheimer’s drug developmentSTAT
  • 10h agoSTAT+: Two FDA approvals — a new drug and a new vaccineSTAT
  • 10h agoU.S. moves to shut a Kentucky organ donation group, citing safety failuresSTAT